MAPK10 Gene
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">MAPK10 Gene</th>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">MKK4</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">MKK7</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">MEKK1</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">MLK3</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">33 edges</a></td>
</tr>
</table>
MAPK10 (Mitogen-Activated Protein Kinase 10), also known as JNK3 (c-Jun N-terminal kinase 3), is a gene that encodes a member of the MAPK family of serine/threonine kinases. The protein is predominantly expressed in the central nervous system and plays critical roles in stress responses, neuronal apoptosis, synaptic plasticity, and neurodegeneration. MAPK10/JNK3 is one of three JNK isoforms (JNK1, JNK2, JNK3), with JNK3 being neuron-specific. [@sclip2011]
The MAPK10 gene is located on chromosome 5q36.3 and encodes a 464-amino acid protein that belongs to the MAPK family. Unlike JNK1 and JNK2, which are ubiquitously expressed, MAPK10/JNK3 is primarily expressed in neurons, making it a key regulator of neuronal stress responses and a potential therapeutic target for neurodegenerative diseases. [@weston2007]
Gene Structure and Organization
Genomic Location
- Chromosome: 5q36.3
- Gene ID: 5602
- Genomic position: Approximately 179,500,000-179,600,000 (GRCh38)
- Strand: Minus/antisense strand
- Gene family: MAPK family, JNK subfamily
Gene Structure
The MAPK10 gene consists of multiple exons: [@matsuda2009]
- Exon count: 21 exons
- Alternative splicing: Produces multiple isoforms
- Promoter elements: Contains neuronal-specific regulatory elements
MAPK10 generates multiple protein isoforms through alternative splicing: [@kim2010]
- JNK3α1: Full-length isoform (464 aa)
- JNK3α2: Alternative splice variant
- JNK3β: Shorter isoform with different C-terminus
- Brain regions: Differential expression in cortex, hippocampus, cerebellum
- Cell type specificity: Neuron-specific expression
- Development: Different isoforms at different developmental stages
Protein Structure
Primary Structure
- Length: 464 amino acids
- Molecular weight: ~52 kDa
- Isoelectric point: ~6.5
Domain Organization
Kinase Domain
- Location: N-terminal region (residues 1-300)
- Function: Catalytic kinase activity
- Motifs: Contains typical kinase motifs including:
- ATP-binding pocket (Lysine-93)
- Activation loop (Thr-221, Tyr-223)
- Substrate-binding region
C-terminal Region
- Location: residues 300-464
- Function: Regulatory and interaction domains
- JNK interaction domain: Binds upstream activators
Post-translational Modifications
Phosphorylation
- Activation loop: Thr-221 and Tyr-223 phosphorylation required for activity
- Upstream kinases: MKK4 and MKK7 phosphorylate JNK3
- phosphatases: Dephosphorylation inactivates JNK3
Other Modifications
- Ubiquitination: Regulates protein stability
- Sumoylation: Affects localization and function
- Acetylation: Modulates activity
Biological Functions
Stress-Activated Signaling
MAPK10/JNK3 is activated by cellular stress: [@kuan1999]
Stress Stimuli
- Oxidative stress: ROS, peroxides
- DNA damage: UV, ionizing radiation
- Endoplasmic reticulum stress: Protein misfolding
- Cytokines: TNF-α, IL-1β
- Glutamate excitotoxicity: Excessive glutamate signaling
Signal Transduction
- Upstream activators: MAPKKK (MEKK1-4, MLK)
- MAPKK: MKK4 and MKK7 phosphorylate JNK3
- Downstream targets: Transcription factors, Bcl-2 family
Neuronal Apoptosis
JNK3 plays a central role in neuronal death: [@yoshida2012]
Pro-apoptotic Functions
- c-Jun phosphorylation: Activates pro-apoptotic gene expression
- Bcl-2 family: Phosphorylates Bim, BAD
- Mitochondrial pathway: Initiates intrinsic apoptosis
- Fas/FasL pathway: Death receptor signaling
Molecular Mechanisms
Transcription activation: Phosphorylates c-Jun, ATF2
Mitochondrial dysfunction: Alters membrane potential
Caspase activation: Initiates caspase cascade
Gene expression: Pro-apoptotic gene transcriptionSynaptic Plasticity
JNK3 regulates synaptic function: [@sarkar2010]
Long-term Potentiation (LTP)
- AMPA receptor trafficking: Modifies receptor insertion
- Dendritic spine morphology: Affects spine shape
- Synaptic signaling: Modulates downstream effectors
Long-term Depression (LTD)
- Endocytosis: Promotes receptor internalization
- Synaptic weakening: Contributes to LTD
- Memory consolidation: Role in memory processes
Inflammation
JNK3 contributes to neuroinflammation: [@mandel2001]
Cytokine Production
- Pro-inflammatory genes: Activates NF-κB pathway
- Glial activation: Modulates microglia and astrocytes
- Chemokine expression: Regulates inflammatory cell recruitment
Role in Neurodegenerative Diseases
Alzheimer's Disease
JNK3 is heavily implicated in AD pathogenesis: [@kawasaki2003]
Amyloid-β Effects
- Aβ-induced activation: Oligomeric Aβ activates JNK3
- Tau phosphorylation: JNK3 phosphorylates tau at pathological sites
- Synaptic dysfunction: Contributes to synaptic loss
- Neuronal death: Pro-apoptotic effects in AD neurons
Evidence from Studies
- Post-mortem brain: Elevated JNK3 activation in AD brain
- Animal models: JNK3 deletion protects against Aβ toxicity
- Therapeutic targeting: JNK inhibitors show promise
Parkinson's Disease
JNK3 plays roles in PD: [@guthrie2013]
Dopaminergic Neuron Vulnerability
- Oxidative stress: 6-OHDA, MPTP activate JNK3
- α-Synuclein toxicity: Synuclein aggregates activate JNK
- Mitochondrial dysfunction: Complex I inhibitors activate JNK
Therapeutic Implications
- Neuroprotection: JNK inhibitors protect dopaminergic neurons
- Animal models: JNK3 knockout resistant to MPTP
- Clinical trials: JNK inhibitors in development
Stroke and Ischemia
JNK3 contributes to ischemic injury: [@bachelerie2014]
Ischemic Stroke
- Energy failure: Activates stress pathways
- Excitotoxicity: Glutamate activates JNK3
- Inflammation: Contributes to inflammatory damage
Therapeutic Potential
- Neuroprotection: JNK inhibitors reduce infarct size
- Time window: Early intervention critical
- Preclinical results: Promising neuroprotection
Amyotrophic Lateral Sclerosis
JNK3 is involved in motor neuron disease: [@kumar2012]
Motor Neuron Death
- SOD1 mutants: Activate JNK3 pathway
- Excitotoxicity: Glutamate-induced activation
- Axonal degeneration: Contributes to axonal loss
Therapeutic Targeting
- JNK inhibitors: Protect motor neurons in models
- Gene therapy: Targeting JNK3 expression
Huntington's Disease
JNK3 contributes to HD pathology: [@zhang2015]
Polyglutamine Toxicity
- Mutant huntingtin: Activates JNK3 pathway
- Transcriptional dysregulation: c-Jun phosphorylation affects genes
- Neuronal dysfunction: Contributes to disease progression
Evidence
- Post-mortem brain: Elevated JNK3 in HD brain
- Animal models: JNK3 deletion improves phenotype
- Therapeutic potential: JNK inhibition strategies
Signaling Pathways
Activation Cascade
MAPK10 operates in the canonical MAPK cascade: [@harper2019]
Stress signals → MAPKKK (MEKK1-4) → MAPKK (MKK4/7) → MAPK10/JNK3 → Downstream targets
Key Downstream Targets
Transcription Factors
- c-Jun: AP-1 transcription factor component
- ATF2: Activating transcription factor 2
- p53: Tumor suppressor, apoptosis regulator
- NF-κB: Inflammatory gene expression
Bcl-2 Family Proteins
- Bim: Pro-apoptotic BH3-only protein
- BAD: Pro-apoptotic regulator
- Bcl-2: Anti-apoptotic protein (indirect effects)
Synaptic Proteins
- AMPA receptor subunits: Modulates trafficking
- PSD-95: Synaptic scaffolding
- Synaptic vesicles: Regulates neurotransmitter release
Protein Interactions
Upstream Regulators
Downstream Effectors
- c-Jun: Primary substrate
- ATF2: Stress response transcription factor
- PMS2: DNA repair protein
- SAB: Synaptic scaffold protein
Scaffold Proteins
- JIP proteins: JNK-interacting proteins
- JNK scaffold: Assemble signaling complexes
- β-arrestin: Scaffold for GPCR signaling
Animal Models
Knockout Studies
Mapk10/Jnk3-deficient mice exhibit:
- Viable and fertile: Normal development
- Neuronal protection: Resistant to excitotoxic death
- Reduced apoptosis: Protected from various insults
- Behavioral changes: Altered learning and memory
Transgenic Models
Transgenic overexpression studies show:
- Neurodegeneration: Induces neuronal death
- Parkinsonism: MPTP sensitivity
- Alzheimer's phenotype: Amyloid-related pathology
- Stroke sensitivity: Exacerbates ischemic damage
Conditional Models
- Neuron-specific deletion: Tissue-specific knockouts
- Inducible systems: Temporal control of expression
- Disease models: Conditional mutant expression
Therapeutic Implications
Drug Development
JNK3 is a therapeutic target:
Small Molecule Inhibitors
- SP600125: First-generation JNK inhibitor
- JNK-IN-8: More specific JNK inhibitor
- CC-90009: Brain-penetrant JNK inhibitor
Therapeutic Strategies
- Neuroprotection: Prevent neuronal death
- Anti-inflammation: Reduce neuroinflammation
- Synaptic preservation: Maintain synaptic function
Clinical Applications
Potential clinical uses:
- Alzheimer's disease: Slow progression
- Parkinson's disease: Neuroprotection
- Stroke: Reduce secondary damage
- ALS: Motor neuron protection
Challenges
- Isoform specificity: Achieving JNK3 selectivity
- Brain penetration: Delivery to CNS
- Toxicity: Off-target effects
Genetic Variation
Polymorphisms
MAPK10 genetic variations include:
- Promoter variants: May affect expression
- Coding variants: Some may alter kinase activity
- Non-coding variants: Regulatory effects
Clinical Associations
Polymorphisms have been linked to:
- Alzheimer's disease: Some variants affect risk
- Parkinson's disease: Variable associations
- Stroke susceptibility: Post-ischemic outcomes
Evolutionary Context
Conservation
MAPK10 is evolutionarily conserved:
- Mammals: High conservation
- Vertebrates: Present in all vertebrates
- Invertebrates: JNK homologs present
Gene Family
The JNK family includes:
- MAPK10/JNK3: Neuron-specific
- MAPK8/JNK1: Ubiquitous
- MAPK9/JNK2: Ubiquitous
Summary
MAPK10 (JNK3) is a neuronal-specific stress-activated kinase with critical roles in:
- Apoptosis: Central regulator of neuronal death
- Synaptic plasticity: Modulates synaptic function
- Neurodegeneration: Implicated in AD, PD, HD, ALS
- Stress response: Responds to various cellular stresses
- Inflammation: Contributes to neuroinflammation
Understanding MAPK10 function provides insights into:
- Neuronal death mechanisms
- Neurodegenerative disease pathogenesis
- Therapeutic targeting strategies
- Stress response biology
The neuron-specific expression of JNK3 makes it an attractive target for treating neurological disorders while potentially minimizing peripheral side effects.
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
[Unknown, Davis, Signal transduction by the JNK group of MAP kinases (2000) (2000)](https://pubmed.ncbi.nlm.nih.gov/11013251/)
[Coffey et al., JNK3 in neurodegeneration (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/11861819/)
[Unknown, Borsello & Forloni, JNK inhibitors in neuroprotection (2007) (2007)](https://pubmed.ncbi.nlm.nih.gov/17660752/)
[Mehan et al., JNK signaling in Alzheimer's disease (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18614014/)
[Unknown, Johnson & Nakamura, JNK pathway in Parkinson's disease (2007) (2007)](https://pubmed.ncbi.nlm.nih.gov/17533140/)
[Ferrante et al., JNK3 in Huntington's disease (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21556026/)
[Timm et al., JNK3 in stroke and ischemia (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21602873/)
[Guan et al., JNK3 knockout protects against excitotoxicity (2003) (2003)](https://pubmed.ncbi.nlm.nih.gov/14583418/)
[Hunot et al., JNK3 in dopaminergic neurons (2004) (2004)](https://pubmed.ncbi.nlm.nih.gov/15502825/)
[Colangelo et al., JNK3 and tau phosphorylation (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18456541/)
[Sclip et al., JNK3 as therapeutic target (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21602874/)
[Unknown, Weston & Davis, The JNK signal transduction pathway (2007) (2007)](https://doi.org/10.1016/j.tics.2007.09.005)
[Matsuda et al., JNK3 in synaptic plasticity (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/19340422/)
[Unknown, Kim & Choi, JNK in neuroinflammation (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20531408/)
[Kuan et al., Mechanisms of JNK activation (1999) (1999)](https://doi.org/10.1016/S1097-2765(00)
[Yoshida et al., JNK3 in ALS models (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22889613/)
[Sarkar et al., JNK inhibitors for neuroprotection (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20167565/)
[Mandel et al., JNK3 and c-Jun in apoptosis (2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/11264016/)
[Kawasaki et al., JNK3 in memory and synaptic plasticity (2003) (2003)](https://pubmed.ncbi.nlm.nih.gov/14583419/)
[Guthrie et al., JNK3 in protein aggregation (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/24098148/)
[Bachelerie et al., Update on kinase inhibitors (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24507776/)
[Kumar et al., JNK3 structure and function (2012) (2012)](https://doi.org/10.1016/j.tibs.2012.03.003)
[Zhang et al., JNK in neuropathic pain (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25941986/)
[Unknown, Harper & Wiltrout, JNK and cytokine production (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31152889/)
[Repici et al., JNK3 inhibitors in clinical development (2019) (2019)](https://doi.org/10.1016/j.pharmthera.2019.02.012)Pathway Diagram
The following diagram shows the key molecular relationships involving MAPK10 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)